Health experts warned that while McDonald’s expansion into regional Australia in the next two years would bode well for local economies, it would not be good for their population’s health.
About a third of the 100 McDonald’s Australia restaurants set to open in the next two years will be in regional and remote areas.
Cameron Newlands, a senior director of the restaurant group, said population growth and government and private investment in regional areas were driving where they would open.
Newlands said the average McDonald’s restaurant fills about 120 full-time, part-time, and casual jobs across different roles from kitchen, service, and management roles in each town, which is substantial in terms of employment opportunity.
But the move is controversial in towns battling obesity and related diseases.
Megan Belot, the president of the Rural Doctors Association of Australia, said that while it’s nice to think that McDonald’s would provide more jobs and opportunities for our younger people, they don’t need fast food in our smaller rural communities who already have an increased risk of obesity.
Belot said the focus for regional communities should be on better access to more fresh food and vegetables and meat.
Dr. Kim Houghton, the chief economist at the Regional Australia Institute, said McDonald’s may be increasingly drawn to the regions as they weren’t as affected by those capital city lockdowns in 2020 due to Covid and bounced back much faster than the city.
Erica Spry, an Aboriginal research officer for the Kimberley Aboriginal Medical Services, said she was very concerned about the effect of fast-food restaurants on the indigenous population, who are seeing increasing rates of diabetes across multiple generations.
Research by Spry and Julia Marley, professor of health research at the rural clinical school of the University of Western Australia, shows Indigenous populations in rural and remote populations can have three times the average rate of diabetes as the general population.


Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Asian Markets Surge as Japan Election, Fed Rate Cut Bets, and Tech Rally Lift Global Sentiment
FDA Fast-Track Drug Reviews Delayed Over Safety and Efficacy Concerns
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
Neuralink Expands Brain Implant Trials with 12 Global Patients
Australian Pension Funds Boost Currency Hedging as Aussie Dollar Strengthens
Jared Isaacman Confirmed as NASA Administrator, Becomes 15th Leader of U.S. Space Agency 



